How can we model the interactions between tumors and the immune system in the lab to deepen our understanding of cancer and its responses to treatment?
Science / Life Sciences
Understanding how the human immune system detects and combats cancer is crucial for developing more effective therapies. Our project involves creating a miniaturized laboratory platform where tumor and immune cells can interact in precise, controlled conditions, thus eliminating the need for animal testing. Using microfluidic technology to mimic blood flow and incorporating three-dimensional tumor models allows us to observe these cellular interactions closely. This approach aims to predict how individual patients might respond to specific treatments. Ultimately, our goal is to create accessible, personalized solutions for the SUS, moving toward more effective, ethical, and cost-efficient healthcare.
Amount invested
Grant Serrapilheira: R$ 350.000,00 (R$ 250.000,00 + R$ 100.000,00 optional bonuses aimed at the integration and training of individuals from underrepresented groups in science.)
Institutions
- Universidade Federal do Rio de Janeiro